Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management.
about
Selective Interleukin-23 p19 Inhibition: Another Game Changer in Psoriasis? Focus on Risankizumab.Safety and Efficacy of Brodalumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis.IL-17 Signaling: The Yin and the Yang.Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors.Interaction of Candida Species with the Skin.Candida infections and interleukin-17 inhibitors used in dermatology.The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function.Investigational drugs in clinical trials for Hidradenitis Suppurativa.The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis.Cost-Effectiveness Analysis of Ixekizumab vs Etanercept and Their Manufacturer-Recommended Dosing Regimens in Moderate to Severe Plaque Psoriasis.Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory Conditions.Safety of biologics in psoriasis.IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model.Interleukin-17-mediated manifestation of psoriasis and tinea.The Role of IL-17 in Protection against Mucosal Candida Infections.Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation.Shifting the Focus: The Primary Role of IL-23 in Psoriasis and other Inflammatory Disorders.Spondyloarthritis, Acute Anterior Uveitis, and Fungi: Updating the Catterall-King Hypothesis.Prevalence and Possible Role of Candida Species in Patients with Psoriasis: A Systematic Review and Meta-Analysis.
P2860
Q38645111-8C7311C1-198B-4B3B-9EC7-84C6959A05F3Q38961129-9B71D0DA-63F6-447A-A23B-08487EE2B0C7Q39158530-7095C11D-F37C-40EF-88D1-CA40A75083FEQ39264020-D898689A-604B-47A2-9715-8FC70EDF65FFQ39356977-084C1D71-EB02-4E49-8FFF-80B65A12A010Q40125170-F1D2DDDF-C189-45C0-9F37-6DEF8D7B4D8CQ46320645-3FB3E808-FB43-4445-B079-9AAC3F596CBCQ47393458-2400BD8A-6BF5-4BDD-8261-683E96A4EF5FQ47644680-C18016E2-231A-4861-BC6E-C00CBFE2740BQ47647524-60164736-8EB1-475C-ABC6-A90F8BC5D97BQ47706029-E993FE45-0DA5-44F7-887A-9A801820E1F0Q47727612-E12B8B65-4FE6-4FAF-9027-27ABC521AC86Q48144965-D18BA612-C3D8-4A3D-B5B6-59ADA6075A97Q48278704-6955049C-5578-4288-8CEF-2E71BC4DAE1FQ48289788-2ECEC05D-CF4D-4248-80DE-A674B205832EQ49184561-82247F27-A96E-43DD-AA83-220F35A0F94EQ49551961-56DED263-BDA8-4EA9-8702-88AEB5DCA561Q50041283-73A5AD06-99A5-4E1E-A1B4-3AD65D283984Q52575771-ECFD46D1-61EE-4B4D-BF61-7D9A262BC5CFQ55041240-CD5C513D-0245-41D3-ACE8-85D6EBECB526
P2860
Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Candida infections in patients ...... nd their practical management.
@en
type
label
Candida infections in patients ...... nd their practical management.
@en
prefLabel
Candida infections in patients ...... nd their practical management.
@en
P356
P1476
Candida infections in patients ...... nd their practical management.
@en
P2093
P356
10.1111/BJD.15015
P407
P577
2016-08-31T00:00:00Z